Aurobindo Pharma to acquire US-based Sandoz units in a $900 million deal; check which businesses it is buying

The acquisition will add approximately 300 products including projects in development as well as commercial and manufacturing capabilities in the US, complementing and expanding Aurobindo's portfolio and pipeline.

from The Financial ExpressThe Financial Express https://ift.tt/2oLFQg5
via IFTTT